Mustang Bio Completes Asset Acquisition/Disposition
Ticker: MBIO · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1680048
Sentiment: neutral
Topics: acquisition, disposition, assets
TL;DR
Mustang Bio just closed a deal on assets. Details in the 8-K.
AI Summary
Mustang Bio, Inc. reported on February 21, 2025, the completion of an acquisition or disposition of assets. The filing also includes other events and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Waltham, Massachusetts.
Why It Matters
This filing indicates a significant corporate action by Mustang Bio, Inc., potentially impacting its asset base and future operations.
Risk Assessment
Risk Level: medium — Asset acquisitions or dispositions can carry inherent risks related to integration, valuation, and future performance.
Key Players & Entities
- Mustang Bio, Inc. (company) — Registrant
- February 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Waltham, Massachusetts (location) — Address of Principal Executive Offices
- 001-38191 (identifier) — Commission File Number
FAQ
What specific assets were acquired or disposed of by Mustang Bio, Inc.?
The filing states the completion of an acquisition or disposition of assets but does not specify the exact assets involved.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported was on February 21, 2025.
In which state is Mustang Bio, Inc. incorporated?
Mustang Bio, Inc. is incorporated in Delaware.
What is the address of Mustang Bio, Inc.'s principal executive offices?
The principal executive offices are located at 95 Sawyer Road, Waltham, Massachusetts.
What is Mustang Bio, Inc.'s Commission File Number?
Mustang Bio, Inc.'s Commission File Number is 001-38191.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding MUSTANG BIO, INC. (MBIO).